Paradoxical worsening of tuberculosis after anti-TB therapy in a kidney transplant recipient.
Asano
T
T
Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan.
Kawamoto
H
H
Asakuma
J
J
Tanimoto
T
T
Kobayashi
H
H
Hayakawa
M
M
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007538:Isoniazid / Q000627:therapeutic use; D016030:Kidney Transplantation; D019520:Living Donors; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D011183:Postoperative Complications / Q000382:microbiology; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy*
D000995:Antitubercular Agents; D007166:Immunosuppressive Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin